Two Sigma Advisers’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,864,651
Closed -$6.54M 1668
2025
Q4
$6.54M Buy
1,864,651
+68,900
+4% +$236K 0.01% 697
2025
Q3
$5.85M Buy
1,795,751
+305,500
+20% +$962K 0.01% 688
2025
Q2
$3.65M Buy
+1,490,251
New +$7.55M 0.01% 857
2025
Q1
Sell
-10,845
Closed -$136K 2545
2024
Q4
$136K Sell
10,845
-5,200
-32% -$78.3K ﹤0.01% 2180
2024
Q3
$296K Sell
16,045
-12,800
-44% -$262K ﹤0.01% 1914
2024
Q2
$621K Sell
28,845
-48,731
-63% -$1.12M ﹤0.01% 1791
2024
Q1
$2.09M Sell
77,576
-33,000
-30% -$937K ﹤0.01% 1201
2023
Q4
$3.31M Sell
110,576
-75,175
-40% -$1.66M 0.01% 1019
2023
Q3
$3.81M Sell
185,751
-42,700
-19% -$776K 0.01% 873
2023
Q2
$4.54M Sell
228,451
-156,200
-41% -$3.16M 0.01% 818
2023
Q1
$6.59M Sell
384,651
-63,200
-14% -$1.24M 0.02% 695
2022
Q4
$8.76M Buy
447,851
+16,400
+4% +$302K 0.02% 557
2022
Q3
$6.89M Buy
431,451
+78,800
+22% +$1.23M 0.02% 611
2022
Q2
$4.85M Buy
352,651
+78,800
+29% +$939K 0.01% 789
2022
Q1
$4.34M Buy
273,851
+57,200
+26% +$988K 0.01% 856
2021
Q4
$4.73M Buy
216,651
+22,200
+11% +$606K 0.01% 792
2021
Q3
$5.81M Buy
194,451
+18,400
+10% +$670K 0.02% 715
2021
Q2
$7.8M Sell
176,051
-7,200
-4% -$313K 0.02% 658
2021
Q1
$8.13M Buy
183,251
+148,175
+422% +$8.14M 0.02% 649
2020
Q4
$1.92M Buy
35,076
+18,270
+109% +$666K 0.01% 1283
2020
Q3
$384K Buy
16,806
+2,100
+14% +$51.7K ﹤0.01% 1917
2020
Q2
$308K Buy
+14,706
New +$265K ﹤0.01% 2111
2018
Q4
Sell
-8,600
Closed -$212K 2436
2018
Q3
$212K Buy
+8,600
New +$187K ﹤0.01% 2068
2016
Q2
Sell
-9,575
Closed -$283K 2166
2016
Q1
$283K Sell
9,575
-6,275
-40% -$188K ﹤0.01% 1704
2015
Q4
$718K Sell
15,850
-4,100
-21% -$179K ﹤0.01% 1177
2015
Q3
$764K Buy
+19,950
New +$916K ﹤0.01% 1126

Other funds holding RCKT